Latvia - Import of Heparin for Therapeutic Use
Since 2014, Latvia Import of Heparin for Therapeutic Use increased 2.1% year on year. With $42,728.1 in 2019, the country was number 103 comparing other countries in Import of Heparin for Therapeutic Use. Latvia is overtaken by Swaziland, which was ranked number 102 with $44,845.86 and is followed by Bahamas with $41,796. France lead the ranking with $960,128,653.6 in 2019, that is a fall of 6.6% versus 2018. United States, Singapore and Germany respectively ranked number 2, 3 and 4 in this ranking. Belize recorded the best 5 years average growth at +183.7% per year, while Mauritania witnessed the worst performance at -81.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 42,728.10 |
| 2018 | 41,665.43 |
| 2017 | 61,819.68 |
| 2016 | 52,009.82 |
| 2015 | 40,360.63 |
Download all data from 1994 to 2019
How does Latvia rank in Import of Heparin for Therapeutic Use?
| # | 152 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
France
|
960,128,653.60 | 2019 | -6.6 % | -5.3 % | View data | |
| 2 |
#2
United States
|
422,842,642.50 | 2019 | +0.9 % | +2.3 % | View data | |
| 102 |
#102
Swaziland
|
44,845.86 | 2019 | -2.5 % | -18.7 % | View data | |
| 103 |
#103
Latvia
|
42,728.10 | 2019 | +2.5 % | +2.1 % | View data | |
| 104 |
#104
Bahamas
|
41,796.00 | 2015 | +581.8 % | -20.3 % | View data | |